INY-03-041 is primarily utilized in research settings as a selective inhibitor targeting specific biological pathways. It is often employed in studies focused on understanding cellular mechanisms, particularly those involving kinase activity. Researchers use it to explore its effects on signal transduction processes, which can provide insights into disease mechanisms, such as cancer or inflammatory conditions. Its application extends to drug discovery, where it serves as a tool compound to validate potential therapeutic targets. Additionally, INY-03-041 is used in preclinical studies to assess its efficacy and safety profile, contributing to the development of novel treatments for various medical conditions.